Home - Products - Others - Other Targets - 7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid

7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid

CAS No. ———

7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid( ——— )

Catalog No. M38493 CAS No. ———

7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid
  • Description
    7β,15α-Dihydroxy-4,4,14-trimethyl-3,11-dioxochol-8,20-dien-24-oic acid
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CB-6644

    CB-6644 is a selective inhibitor of the RUVBL1/2 complex and blocks the ATPase activity of RUVBL1/2 (IC50 = 15 nM).

  • Lodelcizumab

    Lodelcizumab (LGT 209) is a monoclonal antibody targeting the preprotein convertase Bacillus subtilis protease Kexin-9 (PCSK9) and is used to study hypercholesterolemia.

  • Isocorynoxeine

    Isocorynoxeine shows the effects of lowering blood pressure, vasodilatation, and protection against ischemia-induced neuronal damage.